Thermo Fisher Scientific (TMO) Total Debt (2009 - 2026)

Thermo Fisher Scientific has reported Total Debt for 18 years, with the latest figure at $45.7 billion in Q2 2026.

• Total Debt for Q2 2026 came in at $45.7 billion, up 22.57% year-over-year; the trailing twelve-month figure through Jun 2026 was $45.7 billion (up 22.57% YoY), and the FY2025 annual result was $42.7 billion, up 28.3% from the prior year.
• Total Debt eased to $45.7 billion in Q2 2026, from $46.0 billion in the prior quarter.
• Over five years, Total Debt peaked at $46.0 billion in Q1 2026 and troughed at $30.0 billion in Q4 2022.
• A 5-year average of $38.6 billion and a median of $39.3 billion in 2024 frame the typical range for Total Debt.
• The widest annual swing landed in 2022, when Total Debt jumped 87.28%; it then dropped 13.17% in 2024.
• A 5-year view of Total Debt shows it stood at $39.9 billion in 2022, then dropped by 3.82% to $38.3 billion in 2023, then dropped by 13.17% to $33.3 billion in 2024, then rose by 28.3% to $42.7 billion in 2025, then climbed by 6.9% to $45.7 billion in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $45.7 billion in Q2 2026, $46.0 billion in Q1 2026, and $42.7 billion in Q4 2025.